Nutraceuticals
Can I sell this as a supplement, and what am I allowed to say about it?
FSSAI category and claims work for supplements, functional foods and foods for special dietary use.
We help innovators move from R&D to market through coordinated scientific, regulatory, clinical, quality, manufacturing and commercialisation support — so the route is settled before the evidence is commissioned.
Prequel is a Market Accelerator for nutraceuticals, medical devices, cosmetics and pharmaceuticals — helping innovators move from R&D to market through coordinated scientific, regulatory, clinical, quality, manufacturing and commercialisation support.
Can I sell this as a supplement, and what am I allowed to say about it?
FSSAI category and claims work for supplements, functional foods and foods for special dietary use.
What class is my device, and what evidence does that route require?
Classification, risk management, technical documentation and quality systems for CDSCO and EU routes.
What does it take to put this cosmetic on the Indian market?
COS-1 and COS-2 import registration, State licensing, labelling and claim control for the Indian market.
How do I get this study approved and run in India?
Clinical trial approval, study execution and the full functional stack — our longest-running capability.
A supplement, a face cream, a tablet and a catheter answer to different authorities under different legislation. The boundary between them — where a claim moves a product from one category into another — is where most avoidable cost sits. How we work across the four.
Classification determines what testing and what evidence your product needs. Settle it first and the rest of the programme is planning; settle it late and it is rework.
A regulatory route sets what has to be produced. These are the functions that produce it — the same capability we have run as an FSP for CROs, SMOs and sponsors, now working across all four categories.
Document readiness, submissions & responses in coordination with sponsor/CRO.
Dossier preparation, trackers & clarifications; filings done by sponsor/CRO or by us when authorized.
ICSR intake/processing, E2B checks, QC & medical review support per client safety SOPs.
EDC/eCRF build & validation, DMP/edit checks, coding, queries, freeze/lock support.
SAP, SDTM/ADaM mapping, TLF programming & QC; submission-ready outputs.
Protocol/IB, CSR, narratives and statistical sections aligned to TA context.
Internal/vendor/site audits support, TMF health, deviation/CAPA tracking, inspection readiness.
Program coordination from feasibility through closeout under client SOPs.
On-site/remote visit execution, SDV/SDR and follow-ups per the client monitoring plan.
In-house team training for sponsors, CROs and sites. Individual career courses are run by BCRI.
Parallel EC and contract workflows
Start-up steps run in parallel rather than in sequence, which is where most of the delay sits
SOP-driven quality system
with SOP-driven QMS, TMF health checks, and inspection readiness
RBM monitoring discipline
with RBM monitoring discipline and proactive data quality oversight
Global standards
Operating within Schedule Y, CDSCO pathways, and ICH-GCP requirements
We support CROs, SMOs and sponsors with SOP-driven processes aligned to ICH-GCP and India’s regulatory pathway expectations. Our teams work under client oversight to keep documentation complete and TMF inspection-ready. We provide EC/DCGI coordination support and dossier preparation as requested; submissions are executed by the sponsor/CRO or by us only when formally authorized.
Study conduct, documentation, and oversight mapped to global good-clinical-practice expectations.
Predictable submissions and responses across CDSCO / DCGI pathways and Ethics Committees.
Role-based SOPs, training records, and CAPA discipline to maintain inspection readiness.
Health checks, version control, and document governance for clean TMF at closeout.
*Statements describe internal SOP alignment and operating practices; certificates and vendor tools are disclosed under NDA when applicable.
A standardized, SOP-driven process that keeps governance clear, timelines realistic, and your TMF inspection-ready. We align with ICH-GCP and India’s CDSCO/DCGI pathways while maintaining transparent communication throughout the study.
A few anonymized examples showing how our teams improved start-up speed, monitoring discipline, data quality, and submission readiness across India studies.
We work under sponsor/CRO SOPs and oversight. Our teams integrate with your validated environments to provide execution support across EDC/CDM, Pharmacovigilance, Biostatistics & Programming, TMF/CTMS, and Regulatory/EC coordination. Specific tool stacks are confirmed during onboarding and disclosed under NDA.
We build and maintain study databases under client governance.
Case processing and aggregate support aligned to client safety SOPs.
Programming support inside your validated environment.
Documentation governance and operational tracking under client QMS.
Coordination support with sponsor/CRO as filer of record.
*We operate under client SOPs and licenses. Vendor/tool names are shared during discovery and NDA.
We provide functional service provider (FSP) support to CROs, SMOs and sponsors—working inside your validated environments and under your SOPs & oversight. Choose a model below or mix-and-match for scale.
Best for throughput & continuity
Best for fixed scope & milestones
Best for surge & specialized tasks
Protocol synopsis or portfolio view, SOP map, role mix, access pathways.
Statement of Work with service catalogue, KPIs, and governance cadence.
Access setup, sandbox/UAT, role shadowing, documentation handover.
Monthly governance, KPI review, backlog grooming, and continuous improvement.
*We operate as a support vendor under client SOPs and licenses. Regulatory filings are performed by the sponsor/CRO, or by us only when expressly authorized in writing.
Let’s discuss how our FSP support can strengthen your study execution and quality outcomes.
Typical response: 24 hours